Dapagliflozin Ameliorates Diabetic Kidney Disease via Upregulating Crry and Alleviating Complement Over-activation in db/db Mice

@FPoppelaars @AJPCellPhys Thanks for sharing! It seems that SGLT2 inhibitors exert renal protection by modulating complement activity in many ways...wonder how many of these are direct or secondary to metabolic stressors (high glucose exposure), hypoxia, e

New Research: Dapagliflozin Ameliorates Diabetic Kidney Disease via Upregulating Crry and Alleviating Complement Over-activation in db/db Mice https://t.co/KcXa1FIyRQ #pharmacology